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Abstract. Among 11 isoflavones tested, genistein fYS13J 
produced higher cytotoxic activity against human oral tumor cell 
lines (HSC-2, HSG) than against normal cells (human gingival 
fibroblast. HGF), sugglesting its tumor-speclfic action. Electron 
spin resonance (ESR) spectroscopy showed that YS13 did not 
produce radical, nor scavenged 02e~, generated by hypoxanthine-
xanthine oxidase reaction system, sugg:esting that radical-
mediated oxidation mechanism is not be involved in the YS13-
induced cytotoxicity. Addition of one prenyl gToup produced 
YS18 and YS19 with higher anti-Helicobacter pylori activity. 
Addition of two prenyl g710ups produced YS21 with the highest 
cytotoxic activity but lower tumor-speaficity. Since YS21 
produced the highest amount of radical and most efficiently 
scavenged 02e~ this compound may induce cytotoxicity by 
radical-mediated oxidation mechanism. All isoflavones failed to 
induce anti-human immunodeficiency virus (HIV) activty. 
These data sugglest the medicinal efficacy of isoflavones. 
We have suggested the usefulness of polyphenols (tannins, 
flavonoids, Iignins) for prevention of oral diseases (1). 
Millimolar concentrations of tannin-related compounds 
(epigallocatechin gallate (EGCG), gallic acid, hydrolyzable 
tannins) induced apoptotic cell death (characterized by DNA 
fragmentation and caspase activation) in human leukemic (2) 
and oral tumor cell lines (3, 4). We have recently found that 
flavonoids induced apoptosis in human oral tumor cell lines at 
slightly lower concentrations (5, 6). On the other hand, Iignins 
showed much lower cytotoxic activity, but significantly 
enhanced the cytotoxic activity of ascorbate and vitamin K3 
(7, 8). 
The Sophora species contains different type of flavonoids 
including isoflavones (9). Flavonoids are medicinally 
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important since hey have shown diverse biological activities 
such as antioxidant ( 10-12) , anticarcinogenic ( 13), 
antimutag nic 14), anti-inflammatory (15-17), antiviral (11), 
immunosuppressing (11, 16), nitric oxide-producing (18), 
differentiation-inducing (19) and anticancer (17, 20) activity. 
We have r cently fou d that the antioxidative activity of 
isoflavones, one of the fl vonoids, is superior or similar to 
those of butyl hydroxyltoluenes (21). The antioxidant 
activities of isoflavones d pend on the relation between their 
chemic l structures and reactive oxygen species (22). The 
prenylflavanones ad antitumor, antimicrobial and anti-
human immunodeficiency virus (HIV) activity and we found 
the relationship between radical generation and radical 
scavenging a tivity n prenylflavanones (23). In continuation 
with prev ous studies, we further investigated the relationship 
b tween soflavones and their bioactivity. 
Materials and Methods 
Materials. The following chemicals and reagents were obtained fro~n the 
indicated companies: RPM11640 medium, Dulbecco's modified Eagle 
medium (DMEM) (Gibco BRL, Grand Island, NY, USA); fetal bovine 
serum (FBS) (JRH Bioscience, Lenexa, KS, USA); 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Wako Pure Chem 
Ind., Ltd., Osaka, Japan); 3'-azid0-2',3'-dideoxythymidine (AZT), 
did oxycyiidin  (ddC) (Sigma); dextran sulfate (8 kD) (Kowa, Tokyo); 
diethylenetriaminepentaac tic acid (DETAPAC), gallic acid (Sigma 
Chem. Co., St. Louis, MO, USA); 3,4-dihydr0-2,2-dimethyl-2H-pyrrole-
1-0xide (DMPO) (a spin trap agent) (Aldrich Chemical Co. In, U.S.A.); 
superoxide dismutase (SOD) from bovine erythrocytes (Dojin, 
Kumamoto, Japan); Daidzein [YS1l] (Tokyo Kasei Organic Chemicals, 
Tokyo, Japan). Formononetin [YS12] (24), genistein [YS13] (25), 
biochanin A [YS14] (26), irisolidone rYS15] (26), calycosin [YS16] (27), 
7,4'-dihydroxy-3'-methoxyisoflavone rYS17] (28), Iicoisoflavone A 
rYS18] (29), sophoraisoflavone A [YS19] (27), Iicoisoflavone B [YS20] 
(27) and 6,8-diprenylgenistein [YS2l] (30) were purified and 
charac er zed s described (Figure 1). A strain of Helicobacter pylori 
(ATCC43504) was purchased from the American Type Culture 
Collection (Rockville, MD, USA). 
Assay for cytotoxic activity. Human squamous cell carcinoma (HSC-2), 
human salivary gland tumor (HSG) and human gingival fibroblasts 
(HGF) (5-7 population doubling levels) were cultured in DMEM 
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Table I. Diverse biological activty of isoflavones [YS11-YS21J. 
Compd Cytotoxic actlvityl) 
(CC50 ug/ml) 
Anti--HIV activity 
Human oral tumor H  an S I CC50 
cell line gingival (HGF/HSC-2) (ug/mL) 
fibroblast 
HSC-2 HSG (HGF) 
EC50 SI 
(~g/mL) (CC50/ 
EC50) 
Anti-H,pylori Radical 02~ scavenging actlvity activity~;) generation 
(at pHI0.5) 
MIC50 (ug/mL)3 SOD (U/1.5 mg) 
YSll 
YS12 
YS13 
YS14 
YS15 
YS16 
YS17 
YS18 
YS19 
YS20 
YS21 
114 
596 
31 
28 
1 99 
1 79 
500 
25 
26 
11 
10 
177 
584 
54 
125 
23 3 
142 
5 24 
31 
26 
19 
13 
625 
726 
401 
1 65 
5 29 
206 
583 
38 
41 
20 
15 
5.5 
1.2 
12.9 
5.9 
2.7 
1.2 
1.2 
1.5 
1.6 
1.8 
1 .5 
> 200 
> 200 
?
24 
> 200 
104 
> 200 
39 
41 
?
14 
> 200 
> 200 
> 40 
> 40 
> 200 
> 200 
> 2.00 
>40 
> 200 
?
> 40 
><1 
><1 
<1 
<1 
><1 
<1 
><1 
<1 
<1 
<1 
<1 
>100 
> 100 
> 100 
>100 
> 100 
> 100 
>100 
33 
55 
> 100 
> I OO 
<0-03 
<0.03 
<0.03 
<0.03 
<0.03 
0.13 
< 0.03 
<0.03 
< 0.03 
<0.03 
0.30 
O- 1 3 
0.51 
0.75 
0.78 
0.61 
7.10 
1.10 
1.30 
2.60 
1.50 
14.60 
Dextran sulfate 
Curdlan sulfate 
AZT (uM) 
ddC (uM) 
Clarithromycin 
> 1000 
> 1000 
276 
475 
4.14 
0.72 
0.03 
0.16 
> 242 
> 1396 
829 1 
3012 
10 
1) Near confluent HSC-2 HSG and HGF cells were incubated for 24 hours with various concentrations of each compound and the relative viable cell 
number (A540) was determined by MTT method. Each value represents mean from duplicate determinations. Control (A540) values bf HSC-2 HSG 
and HGF cells were 0.97, 0.54 and 0.31, respectively. 2) ESR condition:see in text. 3) The MIC value was determined for each compound by a broth 
microdilution method using H pylori (ATCC43504) by the following literatures (32 33). 
medium supplemented with 10% heat-inactivated FBS. These cells were 
incubated for 24 hours with the indicated concentrations of test samples. 
The relative viable cell number (absorbance at 540 nm (A540)) was then 
determined by MTr assay. The 50% cyiotoxic concentration (CC50) was 
determined from the dose-response curve (Table I) (4). 
Assay for anti-HW activity (31). Human T cell leukemia virus 1 
(HTLV1)-bearing CD4 positive human T cell lines, MT-4 cells, were 
infected with HIV-InlB at a multiplicity of 5lnfection (m.o.i.) of 0.01. 
HIV- or MOCK-infected MT-4 cells (1.5 x 10 /mL, 200 uL) were placed 
into 96-well microtiter plates and incubated in the presence of various 
concentrations of the fractions in RPM11640 medium supplemented 
with 10% FBS. After incubation for 5 days at 37'C in a 5% C02 
incubator, cell viability was quantified by a colorimetric assay (at 540 um 
and 690 nm), monitoring the ability of viable cells to reduce MTT to a 
blue formazan product. All d~ta represent the mean values of triplicate 
measurements. CC50 was determined with MOCK-infected cells, 
whereas EC50 was determined with HIV-infected cells. The selectivity 
index (SI) was defined as follows: SI=CC50/EC50 (Table I) (31). 
Anti-Helicobacter pylori activity. A strain of Helicobacter pylori 
(ATCC43504) was purchased from the American Type Culture 
Collection (Rockrille, MD, USA). Mueller-Hilton broth containing 5% 
FBS was used as the m dium and was cultured in a jar conditioned with 
Campylo Pack (Dia latron) for 48 hours. Briefly, H. pylori strains were 
inoculated on a Brucella agar plate containing 10% horse serum, and 
cultured at 37'C for 48 hours. The bacterial colonies collected were 
diluted to l07 colony forming units (CFU)/mL with 0.9% saline. The 
extracts were dissolved in DMSO and then diluted with Mueller-Hilton 
broth. To the solution60f the extracts, each bacterial suspension was 
added to a density f 10 colony forming units (CFU)/100 mL/well. The 
mixture was incubated at 37'C for 48 hours. The minimum inhibitory 
conc ntration (MIC) of each fraction was calculated from the dose-
response curve (32, 33) (Table I). 
Assay f r adical intensity. Radical intensity was determined at 25 ' C 
(RT) using ESR spectroscopy (JEOL JES REIX, X-band, 100 kHZ 
modulation frequency). Instrument settings: center field, 335.6 :t 5.0 
mT; microwave power, 8 mW; modulation amplitude, 0.1 mT; gain, 630 
t me constant, 0 1 s conds; scanning time, 2 minutes. Radical intensity 
was determined in 0.1M NaHC03/Na2C03 buffer (pH 10.5) containing 
50% DMSO. The final concentration of compound was 3 mg/mL and the 
radical intensity was defined as the ratio of peak heights of these radicals 
to that of MnO (Figure 2) (34). 
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Superoxide anion (02e~) scaven8ing activity,. A superoxide anion radical 
(02e~) was generated by hypoxanthine (HX) and xanthine oxidase 
(XOD) system (200 uL) [2 mM HX (in 0.1 M phosphate buffer, pH 7.8) 
(PB) 50 uL, 0.5 uM DETAPAC 20 uL, DMPO 10 uL, sample (in 
DMSO) 50 uL, H20 or SOD 30 uL, SOD (0.5 U/mL in 0.1M PB) 40 uL]. 
After I minutes, the measurement was begun. The gain was changed to 
250. 02e~ scavenging activity was expressed as SOD unit/1.5 mg sample 
(Table I) (35). 
Results 
Structure-activity relationship. We first compared the cyiotoxic 
activity and tumor specificity (as measured by CC50 against 
HGF/CC50 against HSC-2 (SI)) of 11 isoflavones (Table I)~ 
Daidzein [YS1l] and formononetin rYS12] (OH at C-4' 
position were replaced with OCH3 in YS11) showed weak 
cytotoxicity against human oral tumor cell lines (HSC-2, 
HSG) (CC50=114, 117; 596, 584 u~mL), but much weaker 
cyiotoxicity against normal cells (HGF) (CC50=625, 726 
ugimL), suggesting their tumor-specific action (SI=5.5, 1.1) 
(Table I). Addition of the OH group to C-5 of YS11 or YS12 
produced genistein [YS13] and biochanin A nrS14], which 
showed higher cyiotoxic activity (CC50=31, 54; 26, 125 
ugimL) and tumor specificity (SI= 12.9, 5.9). Further addition 
of OCH3 group to C-6 of YS14 produced irisolidone rYS15], 
which showed reduced cyiotoxic activity (CC50=199, 233 
u~mL). On the other hand, the addition of OH or OCH3 
groups to C-3 ' of YS12 or YS11 produced calycosin n(S16] 
(CC50 = 1 79, 1 42 u~mL) and 7,4 '-dihydroxy-3 '-
methoxyisoflavone rYS17] (CC50=500, 524 u~mL), which 
showed comparable activity with YS11 or YS12, respectively. 
These data suggest that YS13 or YS14 might be the minimum 
structure required for production of higher cyiotoxicity and 
tumor-specificity. Further addition of one or two prenyl 
groups produced licoisoflavone A [YS18] and 6,8-
diprenylgenistein rYS2l], which have slightly higher 
cyiotoxicity (CC50=25, 31; 10, 13 ugimL), but reduced tumor 
specificity (SI=1.5, 1.5). An addition of 2,2-dimethyl-
chromene ring to 5,7,4' or 2'-trihydroxyisoflavone produced 
sophoraisoflavone A rYS19] or licoisoflavone B rYS20], which 
had also higher cyiotoxicity (CC50=26, 26; 11, 19 ug/mL), but 
reduced tumor specificity (SI= 1.6, 1.8) (Table I). 
Anti-human immunodeficiency virus (HIV) activity. A11 
isoflavones rYS11-YS2l] showed no apparent anti-HIV 
activity (SI<1), in contrast to popular anti-HIV agents, such 
as dextran sulfate (SI=154), curdlan sulfate (SI>1396), AZT 
(SI=8291) and ddC (SI=3012) (Table I). 
Anti-Helicobacter pyroli activity. YS18 and YS19 showed 
slightly weaker anti-H. pylori activity (CC50=33 and 55 ugimL, 
respectively) than clarithromycin (CC50=10 u~mL). On the 
other hand, other isoflavones were inactive (Table I). 
Radical generation and 02e~ scavenging activity. ESR 
spectroscopy demonstrates that YS16 and YS21 produced 
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Figure 2. ESR spectra of 11 isoflavones (3 mglmL) m O IM 
NaHC031Na2C03 (pHIO. 5). 
radical(s) under alkaline condition (pH 10.5), whereas other 
isoflavones produced no detectable radical (Figure 2). 
YS21 scavenged most efficiently 02e~, produced 
hypoxanthine-xanthine oxidase reaction system. Titration with 
superoxide dismutase (SOD) standard demonstrated that 
YS21 had the highest SOD activity (146 SOD unit/1.5 mg), 
followed by YS16 (7.1 SOD unit/1.5 mg) (Table I). Other 
isoflavones had much redueed SOD activity (<2.5 SOD 
unit/1.5 mg). When radical intensity.was plotted as a function 
of SOD activity, a positiv9 relatiohship was found between 
these two parameters (Figure 3'). ~; ' -. 
Discussion 
The present study demonstrated that among 11 isoflavones, 
genistein ~(S13] showed the highest tumor-specific cyiotoxic 
activity (SI=12.9). Since this genistein n(S13] did not show 
de ectable r dical production nor 02e~ scavenging activity, 
YS13 might induce cyiotoxicity by non-oxidation mechanism. 
On the other hand, the addition of two isoprenyl groups to 
YS13 produced 6,8-diprenylgenistein rYS2l], which showed 
much higher cyiotoxic activity than YS13, but lesser tumor-
specific ty. Of note, YS21 produced the highest amount of 
radical, suggesting that YS21 might produce cyiotoxicity by a 
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Figure 3. Relationship between radical generation (at pH 10.5) and 
scavenging (SOD) activity (at pH 7. 8) . 
02'~
radical-mediated oxidation mechanism. Therefore, combi-
nation with other compounds which show tumor-specificity, 
such as ascorbate, benzaldehyde, epigallocatechin gallate, 
macrocyclic ellagitannins, curcumin, dopamin, flavonoids, 
steroidal saponins (4, 5, 36, 37) might furhter potentiate the 
cytotoxic activity of YS21. 
We also found that YS21 not only produced the highest 
amount of radicals, but showed the highest 02e~ scavenging 
activity. This suggests that YS21 acts as both an antioxidant 
and a prooxidants, depending on the condition where YS21 is 
present. We have previously reported that sodium ascorbate 
(38) and vitamin K3 (39) displayed similar bimodal action. 
The mechanism by which these isoflavones switch antioxidant 
action to prooxidant action and vice versa remains to be 
investigated. 
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